期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

副神经节瘤的诊治现状及进展 被引量：1

下载PDF
导出
摘要 嗜铬细胞瘤来源于肾上腺素能系统的嗜铬细胞，主要发生在肾上腺髓质，也可发生在肾上腺外的交感神经系统。发生在肾上腺外的称之为副神经节瘤。肿瘤可发生于颅底至盆腔的任何部位，
作者 王亮 李黎明
机构地区 天津医科大学总医院泌尿外科
出处 《天津医科大学学报》 2013年第5期430-432,共3页 Journal of Tianjin Medical University
关键词 副神经节瘤 诊治 进展
分类号 R737 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Shah U, Giubellino A, Pacak K. Pheochromocytoma: implications in tumorigenesis and actual management[J]. Minerva Endocrinol, 2012, 37(2): 141.
  • 2Biggar M A, l,ennard T W. Systematic review of pheochromocytoma in pregnancy[J]. Br J SLJrg, 2013, 100(2): 182.
  • 3Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: rec- ommendations for clinical practice from the First International Symposium[J]. Nat Clin Pratt Endocrinol Metab, 2007, 3(2): 92.
  • 4Stolk R R, Bakx C, Muhler J, et al. Is the excess cardiovascular morbidiiy inpheochromoeytoma related to blood pressure or to care- clmlamines[J]. J Clin Endocrinol Metab, 2013, 98(3): 1100.
  • 5Mullins F, O'Shea P, FitzGerald R, et al. Enzyme-linked im- munoassay tot plasma-free metanephrines in the biochemical di-agnosis of pheochromocytoma in adults is not ideal[J]. Clin Chem Lab Med, 2011, 50(1): 105.
  • 6Karagiannis A, Mikhailidis D P, Athyros V G, et al. Pheoehromoey- toma: an update on genetiee and management[J]. Etdoer Relat Caneer, 2007, 14(4): 935.
  • 7Christensen T T, Frystyk J, Poulsen P L, et al. Comparison of plas- ma metanephrines measured by a e+ommercial immunoassay and urinary eateeholamines in the diagnosis of pheoehronmeytoma Seand[J]. J Clin Lab Invest, 2011,71 (8): 695.
  • 8Davidson D F, Bradshaw N, Perry C G, et al. Urinary free (uneon- jugated) metadrenalines in different hereditary forms of eate- eholamine-seereting phaeoehromoeytoma/paraganglioma[J]. Ann Clin Bioehem, 2012, 49(5): 486.
  • 9Timmers H J, Taieb D, Paeak K. Current and future anatomical and functional imaging approaches to pheochromoeytoma anti paragan- glioma[J]. Horm Metab Res, 2012, 44(5): 367.
  • 10Bittner J G, Brunt L M. Evaluation and management of adrenal in- eidentaloma [J]. J Surg Oncol, 2012, 106(5): 557.

二级参考文献9

  • 1Kwekkeboom DJ, Krenning EP.Somatostatin receptor imaging. Semin in Nucl Med, 2002, 32(2):84-91
  • 2Bakker WH, Albert R, Bruns C, et al. 111ln-DTPA-D-Phe1octreotide, a potentialradiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis,radiolabelling and in vitro validation. Life Sci, 1991, 49(22):1583-1591
  • 3Krenning EP, Bakker WH, Breemon WAP, et al. Localisation of endocrine-relatedtumors with radioiodinated analogue of somatostatin. Lancet, 1989, 1(8632):242-244
  • 4Decristoforo C, Mather SJ, Choleewinski W, et al. 99TcmEDDA/HYNIC-TOC: a new99Tcm-labelled radiopharmaceuticl for imaging somatostatin receptor-positive tumours:first clinical results and intra-patient comparison with 111In-labelled octreotidederivatives. Eur J Nucl Med, 2000, 27(9):1318-1325
  • 5Boernan OC, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a newclass of radiopharmaceuticals. Semin in Nucl Med, 2000, 30(3):195-208
  • 6Olsen JO, Pozderac RV, Hinkle G, et al. Somatostatin receptor imaging ofneuroendocrine tumors with IndiumPentetreotide (OctreoScan). Semin in Nucl Med, 1995,25(3):251-261
  • 7Jong MD, Valkema R, Jamar F, et al. Somatostatin receptor-targeted radionuclidetherapy of tumors: preclinical and clinical findings. Semin in Nucl Med, 2002,32(2):133-140
  • 8Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scitintigraphywith (111In-DTPA-Phe) and (123I-Try3)-octreotide: the Rotterdam experience with more than1000 patients. Eur J Nucl Med, 1993, 20(8):716-731
  • 9张宝牛,李方,陈方.生长抑素受体显像在甲状腺髓样癌诊断中的应用[J].中华核医学杂志,2000,20(1):3-4. 被引量：5

共引文献5

同被引文献7

引证文献1

二级引证文献2

天津医科大学学报
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部